Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study group.
Donadieu J, Auclerc MF, Baruchel A, Leblanc T, Landman-Parker J, Perel Y, Michel G, Cornu G, Bordigoni P, Sommelet D, Leverger G, Hill C, Schaison G. Donadieu J, et al. Among authors: bordigoni p. Br J Haematol. 1998 Aug;102(3):729-39. doi: 10.1046/j.1365-2141.1998.00818.x. Br J Haematol. 1998. PMID: 9722300 Free article.
Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study.
Bordigoni P, Esperou H, Souillet G, Pico J, Michel G, Lacour B, Reiffers J, Sadoun A, Rohrlich P, Jouet JP, Milpied N, Lutz P, Plouvier E, Cornu G, Vannier JP, Gandemer V, Rubie H, Gratecos N, Leverger G, Stephan JL, Boutard P, Vernant JP. Bordigoni P, et al. Br J Haematol. 1998 Aug;102(3):656-65. doi: 10.1046/j.1365-2141.1998.00825.x. Br J Haematol. 1998. PMID: 9722290 Free article. Clinical Trial.
Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE).
Donadieu J, Auclerc MF, Baruchel A, Perel Y, Bordigoni P, Landman-Parker J, Leblanc T, Cornu G, Sommelet D, Leverger G, Schaison G, Hill C; French Acute Lymphoblastic Leukaemia Group (FRALLE). Donadieu J, et al. Among authors: bordigoni p. Br J Cancer. 2000 Dec;83(12):1617-22. doi: 10.1054/bjoc.2000.1504. Br J Cancer. 2000. PMID: 11104555 Free PMC article.
Vaccination and the risk of childhood acute leukaemia: the ESCALE study (SFCE).
Mallol-Mesnard N, Menegaux F, Auvrignon A, Auclerc MF, Bertrand Y, Nelken B, Robert A, Michel G, Margueritte G, Perel Y, Méchinaud F, Bordigoni P, Leverger G, Baruchel A, Hémon D, Clavel J. Mallol-Mesnard N, et al. Among authors: bordigoni p. Int J Epidemiol. 2007 Feb;36(1):110-6. doi: 10.1093/ije/dyl270. Epub 2007 Jan 16. Int J Epidemiol. 2007. PMID: 17227780 Free PMC article.
Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol.
Gandemer V, Pochon C, Oger E, Dalle JH, Michel G, Schmitt C, de Berranger E, Galambrun C, Cavé H, Cayuela JM, Grardel N, Macintyre E, Margueritte G, Méchinaud F, Rorhlich P, Lutz P, Demeocq F, Schneider P, Plantaz D, Poirée M, Bordigoni P. Gandemer V, et al. Among authors: bordigoni p. Br J Haematol. 2014 May;165(3):392-401. doi: 10.1111/bjh.12749. Epub 2014 Jan 30. Br J Haematol. 2014. PMID: 24479958 Free article. Clinical Trial.
Economic evaluation of recombinant human granulocyte colony-stimulating factor in very high-risk childhood acute lymphoblastic leukemia.
Delorme J, Badin S, Le Corroller AG, Auvrignon AA, Auclerc MF, Gandemer V, Bordigoni P, Lamagnere JP, Demeocq F, Perel Y, Berthou C, Bauduer F, Pautard B, Vannier JP, Braguer D, Leblanc T, Leverger G, Baruchel A, Michel G. Delorme J, et al. Among authors: bordigoni p. J Pediatr Hematol Oncol. 2003 Jun;25(6):441-7. doi: 10.1097/00043426-200306000-00004. J Pediatr Hematol Oncol. 2003. PMID: 12794521 Clinical Trial.
A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle Osseuse.
Cavazzana-Calvo M, Bordigoni P, Michel G, Esperou H, Souillet G, Leblanc T, Stephan JL, Vannier JP, Mechinaud F, Reiffers J, Vilmer E, Landman-Parker J, Benkerrou M, Baruchel A, Pico J, Bernaudin F, Bergeron C, Plouvier E, Thomas C, Wijdenes J, Lacour B, Blanche S, Fischer A. Cavazzana-Calvo M, et al. Among authors: bordigoni p. Br J Haematol. 1996 Apr;93(1):131-8. doi: 10.1046/j.1365-2141.1996.4831024.x. Br J Haematol. 1996. PMID: 8611446 Clinical Trial.
Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Michel G, Leverger G, Leblanc T, Nelken B, Baruchel A, Landman-Parker J, Thuret I, Bergeron C, Bordigoni P, Esperou-Bourdeau H, Perel Y, Vannier JP, Schaison G. Michel G, et al. Among authors: bordigoni p. Bone Marrow Transplant. 1996 Feb;17(2):191-6. Bone Marrow Transplant. 1996. PMID: 8640165 Clinical Trial.
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
Michel G, Landman-Parker J, Auclerc MF, Mathey C, Leblanc T, Legall E, Bordigoni P, Lamagnere JP, Demeocq F, Perel Y, Auvrignon A, Berthou C, Bauduer F, Pautard B, Schneider P, Schaison G, Leverger G, Baruchel A. Michel G, et al. Among authors: bordigoni p. J Clin Oncol. 2000 Apr;18(7):1517-24. doi: 10.1200/JCO.2000.18.7.1517. J Clin Oncol. 2000. PMID: 10735900 Clinical Trial.
247 results